FindTrial
Sign In

Effect of gestational diabetes on maternal postpartum glucolipid metabolism, inflammatory markers, and offspring obesity

Effect of gestational diabetes on maternal postpartum glucolipid metabolism, inflammatory markers, and offspring obesity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067592
Enrollment
Unknown
Registered
2023-01-12
Start date
2023-01-12
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

GDM group:None
Non-GDM group:N/A

Sponsors

Peking University International Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women with GDM and non-GDM were included according to the diagnostic criteria of the "Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes Mellitus (2002 edition)" recommended by the Chinese Medical Association's Division of Diabetes Mellitus in 2017-2019 for pregnant women who were established at Peking University International Hospital.

Exclusion criteria

Exclusion criteria: Diabetes mellitus (both type 1 and type 2) clearly diagnosed before pregnancy; overt diabetes mellitus during pregnancy; women who have been treated with glucose-lowering drugs or insulin during pregnancy; twin or multiple pregnancies; concomitant rheumatic immune system disease; severe hepatic and renal insufficiency; long-term use of antidepressants or corticosteroids.

Design outcomes

Primary

MeasureTime frame
Glycated hemoglobin;Blood lipids;Inflammatory indicators;—

Countries

China

Contacts

Public ContactXiaomei Zhang

Peking University International Hospital

z.x.mei@163.com13716781136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026